BLCO Stock Analysis: Buy, Sell, or Hold?
BLCO - Bausch + Lomb Corporation
$15.90
0.64 (4.19%)
▲
5d:
+1.21%
30d:
-13.63%
90d:
-7.29%
BUY
MODERATE Confidence
Analysis Updated: Mar 31, 2026 12:00 AM ET
Earnings: Apr 29, 2026
27d
Get Alerted When BLCO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: BLCO shows positive signals but monitor for confirmation. Market pricing in 8.6% decline. Moderate conviction.
💡 BUY OPPORTUNITY: BLCO shows positive signals but monitor for confirmation. Market pricing in 8.6% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$40.65
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$25.24
37.0% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 19.5x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: BLCO is currently trading at $15.90, which is considered slightly low relative to its 30-day fair value range of $15.85 to $17.98. From a valuation perspective, the stock is trading at a discount (Forward PE: 14.8) compared to its historical average (19.5). Remarkably, the market is currently pricing in an annual earnings decline of 8.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, BLCO is in a strong uptrend. Immediate support is located at $15.14, while resistance sits at $16.80. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: BLCO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $18.46 (+16.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BLCO is in a strong uptrend. Immediate support is located at $15.14, while resistance sits at $16.80. The stock is showing strong short-term momentum, up 4.2% recently.
Market Sentiment: BLCO has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $18.46 (+16.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$15.85 -
$17.98
Company Quality Score
53/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
67.3%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.2%)
- BULLISH: Trading below Wall St target ($18.46)
Fair Price Analysis
30-Day Fair Range
$15.85 -
$17.98
Current vs Fair Value
SLIGHTLY LOW
Expected Move (7 Days)
±$1.05
(6.6%)
Support & Resistance Levels
Support Level
$15.14
Resistance Level
$16.80
Current Trend
Strong Uptrend
Technical data as of
Mar 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
14.85
Wall Street Target
$18.46
(+16.1%)
Revenue Growth (YoY)
9.8%
Earnings Growth (YoY)
-88.6%
Profit Margin
-7.1%
Valuation Discount vs History
-8.6% cheaper
PE vs Historical
14.9 vs 19.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.6%
(market-implied from PE analysis)
1-Year Target
$14.53
(-9%)
2-Year Target
$13.28
(-17%)
3-Year Target
$12.14
(-24%)
3-Yr Target (if PE normalizes)
(PE: 15→20)
$15.94
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 37.0%)
$61.47
(+287%)
Base:
(SPY PE: 14.9, Growth: 37.0%)
$40.85
(+157%)
Bear:
(PE: 12.6, Growth: 37.0%)
$34.72
(+118%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 14.9 to 19.5
Stabilization Target:
$20.88
(+31.3%)
PE Expansion Potential:
+31.3%
Share & Embed Analysis
Last updated: April 01, 2026 5:12 AM ET
Data refreshes hourly during market hours. Next update: 6:12 AM
Data refreshes hourly during market hours. Next update: 6:12 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BLCO showing a specific setup today?
Insider Activity (6 Months)
3
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
A Robert D Bailey
BUY
14600 shares
2026-03-06
Brent L Saunders
BUY
14700 shares
2026-03-06
Sam Eldessouky
BUY
4000 shares
2026-03-06
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$94 | 54 HOLD |
|
ISRG
Intuitive Surgical Inc |
BUY
33 analysts |
$607 | 48 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
19 analysts |
$186 | 61 BUY |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
13 analysts |
$318 | 62 BUY |
|
RMD
ResMed Inc |
BUY
19 analysts |
$297 | 59 HOLD |
